Cyril Amarchand Mangaldas

Press Releases

Cyril amarchand mangaldas advises indian banks’ association (“iba”) on revised model for assignment agreement and trust deeds.

Cyril Amarchand Mangaldas (CAM) advised Indian Banks’ Association (“IBA”)  with the preparation of the revised draft of the model Assignment Agreement for transfer / assignment of financial assets by Banks & Financial Institutions,

18 July 2024

Press Releases

Cyril amarchand mangaldas advised aditya birla capital limited on the offer for sale of equity shares of aditya birla sun life amc limited.

April 29, Mumbai/ Bengaluru: Cyril Amarchand Mangaldas (CAM) advised Aditya Birla Capital Limited on the offer for sale of equity shares of face value ₹ 5 each (“Equity Shares”) of Aditya Birla Sun Life AMC Limited (the “Company”)(“Offer”),

30 April 2024

Press Releases

Cyril amarchand mangaldas advised consortium of sumitomo corporation, osaka gas co. Ltd and japan overseas infrastructure investment corporation for transport & urban development (join) (investors) with respect to primary investment in ag&p lng marketing pte. Ltd engaged in city gas distribution business in india.

April 22, Delhi/Mumbai: Cyril Amarchand Mangaldas has advised a Japanese consortium comprising Osaka Gas, the second-largest city gas distributor in Japan, Sumitomo Corporation,

22 April 2024

Press Releases

Cyril amarchand mangaldas advised collective newsroom private limited in restructuring of bbc’s india operations, establishing new indian owned entity and acquisition of digital news business

April 19, Delhi/Mumbai: Cyril Amarchand Mangaldas advised Collective Newsroom Private Limited (Collective Newsroom), a new Indian owned and controlled entity set up by senior employees of The British Broadcasting Corporation (BBC) in India,

22 April 2024

Press Releases

Cyril amarchand mangaldas advises alpha alternatives in acquisition of stakes in dilip buildcon limited and spvs of dilip buildcon limited

April 15, Delhi/Mumbai: Cyril Amarchand Mangaldas advises Alpha Alternatives in acquisition of stakes in Dilip Buildcon Limited and SPVs of Dilip Buildcon Limited.

16 April 2024

Press Releases

Cyril amarchand mangaldas advises fresenius medical care india pvt ltd ("fmc") on equitable igst rates for dialysis equipment imports.

April 12, Delhi/Mumbai: Cyril Amarchand Mangaldas advises Fresenius Medical Care India Pvt Ltd ("FMC") on Equitable IGST Rates for Dialysis Equipment Imports.

16 April 2024

Press Releases

Cyril amarchand mangaldas advises icici prudential corporate credit opportunities (acting through its investment manager i.E. Icici prudential asset management company limited) on subscribing to secured and redeemable non-convertible debentures issued by purva good earth properties private limited.

April 11, Delhi/Mumbai: Cyril Amarchand Mangaldas advises ICICI Prudential Corporate Credit Opportunities (acitng through its investment manager i.e. ICICI Prudential Asset Management Company Limited) on subscribing to secured and redeemable non-convertible debentures of INR 115,00,00,000 ("Debentures")  issued by Purva Good Earth Properties Private Limited ("Purva Good Earth").

16 April 2024

Press Releases

Cyril amarchand mangaldas advises icici bank limited and axis bank limited in issuance of listed ncds by delhi international airport limited.

April 11, Delhi/Mumbai: Cyril Amarchand Mangaldas (CAM) advises ICICI Bank Limited and Axis Bank Limited (Arrangers) in issuance of listed, rated, secured, redeemable,

12 April 2024

Cyril amarchand mangaldas advises quess corp limited on its sale of 100% shares of qdigi services limited

March 04, Bangalore/Mumbai: Cyril Amarchand Mangaldas advised Quess Corp Limited on its proposed sale of 100% shares of Qdigi Services Limited, a wholly owned subsidiary, to Onsite Electro Services Private Limited.

05 April 2024

Cyril amarchand mangaldas advises swiss parenterals limited in acquisition of its 70% stake by eris lifesciences limited and its promoter group.

February 27, Ahmedabad/Mumbai: Cyril Amarchand Mangaldas advises Swiss Parenterals Limited (“Swiss”) in acquisition of its 70% stake by Eris Lifesciences Limited (“Eris”) and its Promoter group.

05 April 2024

Press Releases

Cyril amarchand mangaldas announces the establishment of presence in abu dhabi global market (adgm), uae

March 20, 2024, Mumbai: India’s leading law firm, Cyril Amarchand Mangaldas (CAM) announced today the establishment of its presence in Abu Dhabi, United Arab Emirates (UAE).

21 March 2024